Company ProfilePremium

Cirtek Holdings Limited

Company Profile Analysis

Ticker: 1433.HK常達控股有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Cirtek Holdings Limited - Company showcase

Year Founded & Workforce

2019

1,424 Employees

Cirtek Holdings Limited logo

Cirtek Holdings Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Cirtek Holdings Limited Overview

ItemDetailSource
Legal nameCirtek Holdings Limited (常達控股有限公司)FY2024 Annual Report
Former namesNone disclosed—
Founding year (operating group)Not stated in the documents reviewed. The earliest disclosed operating date is February 1992, when Chairman Barry Chan was appointed managing director. The Chairman is credited with 42+ years of industry experience.FY2024 Annual Report (director profiles)
Holding-company incorporationCayman Islands (exempted company). The immediate parent, Charming International Limited (BVI), was incorporated on 2 January 2019.FY2024 Results Announcement
Registered officeVistra (Cayman) Limited, P.O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman KY1-1205 (changed effective 31 Dec 2024)Announcement 10 Jan 2025
Principal place of business (HQ)1/F, Wing Ming Industrial Centre, 15 Cheung Yue Street, Lai Chi Kok, Kowloon, Hong KongFY2024 Annual Report
ListingSEHK Main Board, stock code 1433. Listed 12 March 2020.FY2024 Results Announcement
ISINKYG3000A1040 (as supplied)User-supplied
CUSIPNot applicable / not publicly disclosed—
Fiscal year end31 DecemberAnnual reports
Employees1,424 (31 Dec 2024); 1,219 (2023); 1,164 (2022); 1,050 (2021); 990 (2020)Results announcements FY2021–FY2024
AuditorGrant Thornton Hong Kong Limited (appointed June 2026). Previously PwC (15 Oct 2025 – 29 May 2026) and Ernst & Young (to 15 Oct 2025).EGM circular 1 Jun 2026; TipRanks summary of 15 Oct 2025 announcement
Market capitalisationTrading suspended. Last aggregator snapshot: share price HK$0.08, market cap ≈ HK$162m, P/E 2.95x, P/B 0.67x, dividend yield 9.26% (Lixinger page, last updated 3 Jul 2026; reflects the pre-suspension price).Lixinger
Shares2,000,000,000 issued, of which 8,530,000 are held in treasury (1,991,470,000 outstanding) as at 31 Mar 2026. Par value HK$0.01.Monthly return, 2 Apr 2026 (via iTiger)
Controlling shareholderCharming International Limited, 65.4%. It is owned 51% by Barry Chan and 49% by his spouse Candy Law.FY2024 Annual Report
Websitehttp://www.cirtek.comFY2024 Annual Report
Principal bankersHSBC; Bank of China (Hong Kong); Citibank (Hong Kong)FY2024 Annual Report

Cirtek is a family-controlled, Hong Kong-headquartered micro-cap. It makes the small branded components that sit on almost every garment: woven labels, printed labels, hang tags, heat-transfer labels, packaging and, increasingly, RFID-enabled tags. It sells to apparel brands and to the garment factories that produce for them. Over 2020–2024 it built what management calls a global footprint: a sales network in more than 40 markets and production in Mainland China, Bangladesh, Vietnam, India and Turkey, plus newer plants in Mexico, Guatemala and Southern Europe. The aim is to supply trims "near-shore" to wherever garments are sewn. This strategy delivered record FY2024 results: revenue of HK$551m (+48%), a 49.1% gross margin and net profit of HK$61.9m. However, the investment case is now dominated by a governance event. An auditor-flagged payments issue in Bangladesh, an auditor removal and an open-ended suspension put the listing itself at risk.


Company's own description

In its FY2024 Annual Report, the company describes its principal activities as the manufacture and sale of apparel products such as hang tags, woven labels, printed labels and heat transfer products. In its financial statements it reports a single segment, "manufacture and sale of printing products". The FY2024 MD&A presents the group as a long-standing early mover in apparel labels and trims. It says the group has spent years executing a global deployment strategy and has now moved from an "investment stage" to a "harvesting stage" (FY2024 Results Announcement, 31 Mar 2025).

Business model and revenue model

Revenue model: 100% product sales: All revenue is recognised at a point in time on delivery of printed products (FY2024 Results Announcement, note 4). There is no subscription, licensing or recurring-service revenue line. The RFID software capability acquired with TrueCount (2020) is not reported separately.

Order pattern: Revenue is made-to-order and short-cycle. Remaining performance obligations are described as having an original expected duration of one year or less.

Credit terms: Typically 30–90 days from monthly statements. New customers normally pay in advance (FY2024 note 10).

Customer concentration: low and falling: - FY2024: the top five customers were 8.7% of sales and the largest was 4.1% (FY2023: 9.0% and 5.5%).

  • Earlier, one customer group ("Customer A") exceeded 10% of revenue: HK$31.2m in FY2020, HK$40.9m in FY2021 and HK$43.5m in FY2022. It fell below 10% in FY2023.

  • Sources: FY2024 Annual Report; FY2021 and FY2023 Results Announcements.

Supplier concentration: FY2024: the top five suppliers were 19.2% of purchases and the largest was 8.2% (FY2023: 10.0% and 3.5%).

Value-chain position

Cirtek sits in the apparel "trims and labels" tier, between raw-material suppliers and garment makers:

Upstream suppliers: yarns and ribbons for woven labels, paper and board for tags, inks, film and adhesives for heat transfer, and RFID inlays and chips.

Downstream customers: contract garment manufacturers (CMT/FOB factories in Bangladesh, Vietnam, China, India and Turkey) that are nominated by apparel brands, and the brands and retailers themselves.

The economics of the industry depend on "brand nomination". A brand approves a trim supplier, and its garment vendors worldwide then buy from that supplier locally. This explains why Cirtek co-locates production with garment-export hubs. Customer location (the basis of the geographic revenue split) therefore often reflects where garments are sewn, not where the brand is headquartered.

Customer types and end-markets

Customer types: international and domestic apparel brands (including Mainland Chinese brands; the first two Chinese kids'-apparel brand clients were won in 2021), garment factories, and, through Print100 (印100), SMEs and individuals for quick-print products (B2B and B2C).

End-markets: mainly fashion and apparel retail across Europe, the US, Mainland China and emerging markets. RFID labels also serve retail inventory and logistics management (FY2021 and FY2023 MD&A).

Independent characterisation

Cirtek is a sub-scale but well-diversified trims converter. Its peers are Avery Dennison's apparel solutions business, CCL's Checkpoint/apparel-label operations, Nilörn and private groups such as SML and Trimco.

Strengths: a broad customer base with no customer above about 4% of sales, a multi-country manufacturing footprint, and FY2024 gross margins (49.1%) above Nilörn's (≈46%).

Weaknesses: - Earnings are highly operationally leveraged to apparel order cycles: a net loss in FY2023, then a large profit in FY2024.

  • The group is controlled by one family.

  • The finance and control infrastructure has proven thin for a multi-jurisdiction footprint. Auditors resigned or were removed twice in eight months, and the Bangladesh payments issue triggered the suspension.

Strategy

Stated strategic themes (latest annual report, FY2024; H1 2025 update)

  1. Global deployment and near-shoring. Co-locate trims production with the world's leading garment-export countries. Management describes this as an "offensive yet defensive" global deployment that diversifies risk and lets the group follow brand sourcing shifts, including tariff-driven ones (FY2024 MD&A).

  2. Move from investment phase to harvest / scale-operation phase. Capex was to be cut in 2025 after the peak investment period (FY2024 Chairman's Statement).

  3. RFID as a key growth area. Cross-sell RFID to the existing label customer base, with Europe showing particular demand (FY2024 and H1 2025 MD&A).

  4. Sustainability-led product development. Biodegradable and recycled materials; renewable energy at the China plant (FY2024 MD&A).

  5. Europe via Primway. Use Primway's French and European sales network together with Cirtek's manufacturing scale (FY2024 Chairman's Statement).

  6. Automation and centralised procurement to protect margins (H1 2025 MD&A).

  7. Sales-force expansion in overseas markets (H2 2024 onward), to retain customers and position for recovery (H1 2025 MD&A).

  8. Prudent finance. Control debt, strengthen cash flow and maintain cash reserves (H1 2025 Prospects).

Initiatives announced in the last ~24 months

DateInitiativeDetailSource
Feb 2024Bangladesh plant start-upNew self-built factory operational after relocationFY2024 Results
23 Jul 2024Boluo factory lease renewal15 years (to 2039); avoids relocation and refurbishment costsFY2024 Results
Jul 2024Share buyback10.41m shares at HK$0.04 (HK$0.42m), held as treasuryFY2024 Results
H2 2024Overseas sales-team expansionRaised opex in H1 2025Interim Results 2025
6 Dec 2024UV inkjet printer (Konica Minolta), RMB9.8mCapacity investment for printed productsFY2024 Results
2,024Renewable energy at China plantSolar system targeted "by 2024" in the FY2023 report; FY2024 report says renewable energy is in useFY2023 & FY2024 Results
2,025Capex moderationGuided in the FY2024 Chairman's Statement. H1 2025 PP&E additions were HK$15.9m, higher than H1 2024 (HK$5.6m).FY2024 AR; Interim 2025

Medium-term targets / guidance

Quantified financial targets: none publicly disclosed — no revenue, margin or ROE targets.

Dividend policy: discretionary, with no payout ratio (FY2024 AR).

Current guidance: the only forward quantitative statement is the FY2025 profit warning (PBT ≥ HK$38.0m).

Products & Services

Cirtek does not publish a SKU-level catalogue, list prices or product-level revenue. The table below lists every product line named in its filings.

Flagship offerings. No branded flagship product names are disclosed. The "Charming" trade name is the operating brand across subsidiaries.

Patents. In FY2021 management said it planned to apply for patent registration of its own-developed RFID products. No grant has been disclosed in the filings reviewed (FY2021 Results Announcement).

Product Portfolio

#Product lineDescription / capabilitiesTarget customerLaunch / latest infoPricing modelSource
1

Woven labels

Jacquard-woven brand, size and care labels sewn into garments

Apparel brands and their garment vendors

Core legacy line

Per-unit, order-based; not disclosed

FY2024 MD&A

2

Printed labels

Printed care, content and brand labels on fabric or ribbon substrates

Same as above

Core legacy line

—

FY2024 MD&A

3

Hang tags

Paper and board swing tickets with price, branding and barcodes; capacity added in FY2024 with a UV inkjet printer

Brands and retailers

Core legacy line; UV inkjet capacity added Dec 2024

—

FY2024 MD&A; 6 Dec 2024 announcement

4

Heat transfer products

Tagless heat-applied labels and logos

Sportswear and fashion brands

Core legacy line

—

FY2024 MD&A

5

RFID labels / tags

RFID-enabled trims for item-level inventory and logistics; described as the fastest-growing product (FY2021) and a "key business area" (H1 2025); the RFID share of revenue rose "significantly" in FY2024 (not quantified)

Brands and retailers adopting RFID

Ongoing; R&D emphasis from 2021

—

FY2021, FY2023, FY2024, H1 2025 MD&A

6

RFID software / solutions

Software enabling RFID use, from TrueCount (Dec 2020). Management aims to support smart packaging, smart warehousing, smart stores and data platforms for clients.

Retailers and brands

Acquired 2020; goodwill fully impaired by 2022

—

FY2021 & FY2023 Results Announcements

7

Eco-friendly / sustainable trims

Labels and trims made from biodegradable materials and recycled plastics, responding to brand ESG requirements and tighter EU plastic rules

ESG-focused brands

Expanding since 2021

—

FY2023, FY2024, H1 2025 MD&A

8

Packaging

Packaging products via the Primway associate in France and the Bangladesh "Trim & Packaging" subsidiary; Primway introduced French brand customers in 2024

European (French) brands

Primway stake 2023; integration done in 2024

—

FY2023/FY2024 MD&A

9

Quick-print / personalised printing (印100 / Print100)

Online quick-print platform covering B2B and B2C, SMEs and individuals

SMEs and consumers in Hong Kong

Acquired May 2022; intangible assets impaired FY2023

—

FY2021 & FY2023 Results

“—” = not publicly disclosed.

Financial Narrative

Basis of preparation

  • FY2025 audited results are not published, so the five-year window is FY2020–FY2024. FY2025 indicators are in §6.6.

  • All figures are HK$ millions unless stated, taken from Results Announcements dated 30 Mar 2022 (FY2021/FY2020), 27 Mar 2024 (FY2023/FY2022) and 31 Mar 2025 (FY2024/FY2023), and the FY2024 Annual Report five-year summary.

  • Analyst-computed metrics are labelled. Blank cells mean the figure was not available or not computable from the sources reviewed.

Income statement

Definitions and checks

EBIT: PBT + finance costs − share of associate result. It includes listing expenses (FY2020) and impairments (FY2022–23).

D&A: PP&E depreciation + right-of-use depreciation + intangible amortisation (FY2020: 14.9+10.5+0; FY2024: 20.3+13.5+0.1).

Adjusted figures: FY2020 EBIT excluding listing expenses ≈ HK$17.8m. FY2023 EBITDA excluding impairments ≈ HK$23.4m.

EPS units: the FY2024 EPS of 3.10 is in HK cents. Some aggregators misreport it as HK$3.10, and the dividend as HK$0.75.

Margins and growth

Revenue CAGR FY2020–FY2024: ≈ 20.7% (analyst-computed: 551.0 / 259.3 over 4 years).

Revenue CAGR FY2021–FY2024: ≈ 15.0%.

Balance sheet (31 December)

Banking facilities

Cash flow

They are therefore left blank. Partial disclosures from the MD&A sections follow.

Other cash-flow-related disclosures

  • H1 2025 PP&E additions: HK$15.85m (H1 2024: HK$5.64m).

  • H1 2025 buyback: 50,000 shares for HK$2,000.

  • Source: Interim Results Announcement, 28 Aug 2025.

Ratios (analyst-computed unless stated)

Ratio notes

Invested capital: equity + bank debt + lease liabilities − cash − pledged deposits.

FY2023 ROIC: uses pre-tax EBIT because the year was loss-making.

FY2020 ROE: uses the 31 Dec 2019 equity of HK$144.0m (FY2019 Results Announcement).

Working-capital days: use year-end balances on revenue (DSO) or cost of sales (DIO, DPO).

Latest period and FY2025 indicators

Source: Interim Results Announcement, 28 Aug 2025.

FY2025 profit warning (20 Mar 2026)

  • The board expected FY2025 PBT of not less than HK$38.0m, versus HK$74.7m in FY2024 — a decline of up to about 49%.

  • The stated cause was adverse operating conditions that reduced revenue.

  • Implied H2 2025 PBT is at least about HK$10.1m (HK$38.0m − H1 HK$27.9m), versus about HK$36.9m in H2 2024 (analyst-computed).

  • These figures are unaudited. They predate the auditor's payment concerns. On 30 Mar 2026 the board said it would be inappropriate to publish unaudited management accounts because they may not accurately reflect performance.

Commentary on trends, inflections and drivers

FY2020 – COVID trough and IPO year.

Revenue was HK$259.3m. Gross margin was the highest in the series at 50.2%, helped by mix and lower volumes. The bottom line was almost wiped out by HK$10.6m of one-off listing expenses and FX losses, leaving net profit of HK$1.6m. The IPO cash raised (≈HK$69.9m net) left the group with net cash of about HK$94m excluding leases.

FY2021 – reopening rebound.

Revenue rose 39.8% as COVID restrictions eased, led by Vietnam, Bangladesh and Mainland China. Gross margin compressed by 6.6 points to 43.6%. Cost of sales grew 58.4% because of higher raw-material prices, RMB appreciation and labour costs. Opex rose sharply (S&D +25.6%, admin +21.6%) as new overseas sales offices opened in Guatemala, Mexico and Italy. This is the start of the cost base that later created operating leverage in both directions.

FY2022 – growth with margin dilution.

Revenue grew 12.7% to HK$408.6m. Gross margin slipped to 42.5%. Admin expense climbed to HK$113.4m as footprint investment continued. The first impairment appeared: HK$1.5m on TrueCount goodwill. Cash fell by HK$40m as factory capex and pre-operating costs absorbed liquidity.

FY2023 – inventory-destocking recession.

Revenue fell 8.9% as brands destocked; US textile and apparel imports dropped 22.7% in H1 2023 (company-cited). H1 alone produced an HK$18.8m loss. New plants in Mexico and Turkey carried pre-operating costs while volumes fell. Further impairments followed: Primway associate HK$3.1m, Print100 intangibles HK$4.6m and goodwill HK$0.4m. The full-year loss was HK$25.7m, ROE −11.8% and the current ratio fell to 1.2x. Gross margin held at 43.7%, which suggests the problem was operating leverage, not pricing.

FY2024 – the operating-leverage payoff.

Revenue rose 48.0% to HK$551.0m:

  • Bangladesh +95%, India +89%, Vietnam +58%, Mainland China +38%.

  • The relocated Bangladesh plant started in February 2024, and EU apparel imports recovered (non-EU apparel imports into the EU +28.6% YoY in October 2024, company-cited).

  • Gross margin expanded 5.4 points to 49.1% on scale economies and automation.

  • Opex grew only 2.9% (S&D) and 12.1% (admin).

The result was an EBIT margin of 14.0%, EBITDA of HK$110.8m and net profit of HK$61.9m. Return on equity reached 28.1%. Lease liabilities more than doubled to HK$61.4m because of the 15-year Boluo lease, which lifted reported gearing to 27.5% even though bank debt fell to HK$6.2m. Management declared the group past its "peak investment period" and guided to lower capex in 2025 (FY2024 Chairman's Statement).

2025 – deceleration.

H1 2025 revenue was nearly flat (−2.4%). US customer revenue halved, from HK$7.8m to HK$4.4m, as tariff uncertainty made brands cautious. The sales-force expansion of H2 2024 raised opex, cutting PBT by 26%. The profit warning implies a much weaker H2 2025. The FY2024 surge looks partly cyclical — post-destocking restocking — rather than a permanently higher earnings base.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityJurisdictionRoleSource

Cirtek Holdings Limited

Cayman Islands

Listed holding company

Annual reports

Charming International Limited

BVI

Controlling shareholder (65.4%); owned 51% by Barry Chan and 49% by Candy Law

FY2024 AR

Charming Printing Limited (集美印刷有限公司)

Hong Kong

Principal operating and trading company; senior management employed here

FY2024 AR

Charming Printing (Boluo) Ltd. (博羅縣常美印刷有限公司)

PRC (Guangdong)

Main China production base; lessee of the Boluo factory

FY2024 Results Announcement

Charming China

PRC

China operations (GM Liao Wenwei)

FY2024 AR

Charming US

United States

US sales

FY2024 AR

Charming Trim & Packaging (BD) Ltd

Bangladesh

Bangladesh manufacturing; the subsidiary at the centre of the 2026 payments issue

PwC letter, EGM circular 1 Jun 2026

Lowatag Limited

—

Indirect wholly-owned subsidiary; purchaser of the Primway stake

FY2023 Results Announcement

Print100 Limited (印100)

Hong Kong

Quick-print / online printing

FY2023 Results Announcement

Primway S.A.R.L.

France

Associate (equity-accounted)

FY2023/FY2024 Results

TrueCount (business acquired)

United States (presumed)

RFID software

FY2021 Results Announcement

“—” = not publicly disclosed.

Results by Segment and Segment Margins & Growth (%)

MetricFY2022FY2023FY2024

Segment revenue (HKD Mn)

408.6372.3551.0

Segment gross profit (HKD Mn)

173.5162.6270.6

Segment profit before tax (HKD Mn)

18.8-19.774.7

Gross margin (%)

42.543.749.1

PBT margin (%)

4.6-5.313.6

Revenue growth YoY (%)

12.7-8.948.0

Share of group revenue (%)

100100100

Results by Segment and Segment Margins & Growth (%) (Half-Yearly)

MetricH1 2023H1 2024H1 2025

Revenue (HKD Mn)

160.3264.5258.2

Gross profit (HKD Mn)

62.9124.2121.6

Gross margin (%)

39.346.947.1

Profit before tax (HKD Mn)

-18.137.827.9

Net profit (HKD Mn)

-18.831.324.3

Income Statement and Per-Share Data

MetricFY2020FY2021FY2022FY2023FY2024

Revenue (HKD Mn)

259.3362.5408.6372.3551.0

Cost of sales (HKD Mn)

129.1204.5235.1209.8280.4

Gross profit (HKD Mn)

130.2158.0173.5162.6270.6

Other income and gains (HKD Mn)

9.76.69.56.15.7

Selling and distribution expenses (HKD Mn)

36.545.853.459.561.2

Administrative expenses (HKD Mn)

78.295.1113.4121.1135.6

Listing expenses (HKD Mn)

10.60000

Impairment of non-financial assets (HKD Mn)

001.58.10

Operating income / EBIT, analyst-computed (HKD Mn)

7.223.521.0-16.077.0

Depreciation and amortisation (HKD Mn)

25.427.127.731.333.8

EBITDA, analyst-computed, post-HKFRS 16 (HKD Mn)

32.650.648.715.3110.8

Finance costs (HKD Mn)

2.42.32.23.22.4

Profit before tax (HKD Mn)

4.821.318.8-19.774.7

Income tax (HKD Mn)

3.16.36.26.012.9

Net profit attributable (HKD Mn)

1.615.012.6-25.761.9

Basic EPS (HK cents)

0.090.750.63-1.283.10

Diluted EPS (HK cents)

0.090.750.63-1.283.10

Dividend per share (HK cents)

0.0750.250.2000.75

Margin Analysis (%)

MetricFY2020FY2021FY2022FY2023FY2024

Revenue growth YoY (%)

—39.812.7-8.948.0

Gross margin (%)

50.243.642.543.749.1

Operating (EBIT) margin (%)

2.86.55.1-4.314.0

EBITDA margin (%)

12.614.011.94.120.1

PBT margin (%)

1.85.94.6-5.313.6

Net margin (%)

0.64.13.1-6.911.2

Effective tax rate (%)

65.629.533.1—17.2

S&D expense / revenue (%)

14.112.613.116.011.1

Admin expense / revenue (%)

30.226.227.832.524.6

Balance Sheet

MetricFY2020FY2021FY2022FY2023FY2024

Total assets (HKD Mn)

361.7401.0395.1369.4452.4

Cash and cash equivalents (HKD Mn)

114.7102.162.334.268.5

Pledged deposits (HKD Mn)

0014.114.64.3

Bank borrowings, current (HKD Mn)

20.513.617.921.86.2

Bank borrowings, non-current (HKD Mn)

0.603.01.30

Total bank borrowings (HKD Mn)

21.213.620.923.16.2

Lease liabilities, total (HKD Mn)

33.432.530.225.161.4

Net debt excl. leases, negative = net cash (HKD Mn)

-93.6-88.5-55.6-25.6-66.6

Net debt incl. leases (HKD Mn)

-60.1-56.0-25.4-0.6-5.2

Total equity (HKD Mn)

236.1249.7239.3195.0245.9

Goodwill and intangibles (HKD Mn)

1.82.56.40.70.6

Inventories (HKD Mn)

52.965.168.870.283.2

Trade receivables (HKD Mn)

36.753.742.944.957.6

Trade payables (HKD Mn)

34.755.853.657.364.2

Net working capital / net current assets (HKD Mn)

111.7107.870.428.688.1

Right-of-use assets (HKD Mn)

43.140.636.231.064.0

Property, plant and equipment (HKD Mn)

91.0110.8130.7141.2131.2

Aggregate Facilities by Date

DateAggregate facilitiesUtilised

31 Dec 2021

HK$83.4m

HK$14.5m

31 Dec 2023

HK$130.0m

HK$23.1m

31 Dec 2024

HK$135.6m

HK$6.3m

30 Jun 2025

HK$120.8m

HK$4.1m

Dividends & Capital Returns

MetricFY2020FY2021FY2022FY2023FY2024

Plant and machinery additions disclosed in MD&A (HKD Mn)

—36.9—37.5—

Dividends declared for the year (HKD Mn)

1.55.04.0015.0

Share buybacks (HKD Mn)

00000.42

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2020FY2021FY2022FY2023FY2024

ROE on average equity (%)

0.96.25.1-11.828.1

ROA on average total assets (%)

—3.93.2-6.715.1

ROIC, NOPAT / year-end invested capital (%)

1.48.66.6-8.226.5

Current ratio, reported (x)

2.11.81.51.21.6

Bank debt / equity (x)

0.090.050.090.120.03

Gearing, reported: (bank debt + leases) / equity (%)

23.118.521.324.727.5

Net debt excl. leases / EBITDA (x)

-2.87-1.75-1.14-1.67-0.60

Interest coverage, EBIT / finance costs (x)

3.010.49.5-5.032.6

Asset turnover, revenue / average assets (x)

—0.951.030.971.34

Days sales outstanding (days)

51.754.138.344.038.1

Days inventory outstanding (days)

149.7116.2106.7122.1108.3

Days payables outstanding (days)

97.999.583.299.783.6

Cash conversion cycle (days)

103.570.861.866.462.8

Employees, year-end

9901,0501,1641,2191,424

Revenue per employee (HKD K)

262345351305387

Employee benefit expense excl. directors (HKD Mn)

98.9136.9156.7153.7171.0

Income Statement and Margin Analysis (%)

MetricH1 2024H1 2025Change (%)

Revenue (HKD Mn)

264.5258.2-2.4

Gross profit (HKD Mn)

124.2121.6-2.1

Gross margin (%)

46.947.1—

S&D expenses (HKD Mn)

31.633.76.9

Admin expenses (HKD Mn)

57.360.35.2

Profit before tax (HKD Mn)

37.827.9-26.4

Net profit (HKD Mn)

31.324.3-22.2

Basic EPS (HK cents)

1.561.22—

Cash and equivalents, period-end vs 31 Dec 2024 (HKD Mn)

68.576.2—

Bank borrowings, period-end vs 31 Dec 2024 (HKD Mn)

6.24.0—

Equity, period-end vs 31 Dec 2024 (HKD Mn)

245.9242.3—

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Region

Region (HKD Mn)FY2020FY2021FY2022FY2023FY2024

Mainland China

76.0119.5137.5128.4177.7

Hong Kong

60.474.378.454.764.6

Bangladesh

28.746.860.550.799.0

Vietnam

13.122.843.530.047.5

India

——15.218.034.1

United States

16.223.216.710.7—

Turkey

——7.619.6—

Other countries / regions

64.975.849.360.2128.2

Total

259.3362.5408.6372.3551.0

Region growth YoY (%)

Region growth YoY (%)FY2022FY2023FY2024

Mainland China

15.0-6.638.4

Hong Kong

5.4-30.218.0

Bangladesh

29.3-16.295.3

Vietnam

90.9-31.158.2

India

—18.789.4

United States

-28.3-35.7—

Turkey

—158.7—

Region share (%)

Region share (%)FY2022FY2023FY2024

Mainland China

33.734.532.2

Hong Kong

19.214.711.7

Bangladesh

14.813.618.0

Vietnam

10.78.18.6

India

3.74.86.2

Other incl. US and Turkey

17.924.323.3

Revenue by Region (Half-Yearly)

Region (HKD Mn)H1 2024H1 2025Change (%)

Mainland China

93.585.4-8.6

Bangladesh

44.545.11.4

Hong Kong

27.325.3-7.3

Vietnam

21.624.212.0

India

15.913.1-17.5

United States

7.84.4-44.1

Other countries / regions

53.960.612.5

Locations

Location (HKD Mn)FY2021FY2022FY2023FY2024

Mainland China

97.680.272.8101.1

Bangladesh

29.445.652.247.4

Vietnam

10.210.08.35.3

Hong Kong

2.729.620.718.8

Other countries

17.414.924.730.1

Capital Markets

ItemValueSource / note

Trading status

Suspended (31 Mar / 1 Apr 2026 onward)

§19

Last aggregator price

HK$0.08

Lixinger (page updated 3 Jul 2026)

Market cap at that price

≈ HK$162m

Lixinger

Earlier market-cap snapshots

HK$164m (Mar 2025), HK$186m (Mar 2025), HK$222m (Aug 2025), HK$182m (Oct 2025)

TipRanks announcement pages

Reference prices

HK$0.059 close before the 15 Sep 2020 option grant; HK$0.04 buyback price, Jul 2024

FY2021 & FY2024 Results

Annualised return since listing

−5.36%

Lixinger

Average daily volume (2025)

≈ 2.3m–4.1m shares

TipRanks

Valuation Multiples

MultipleCirtekNote

P/E (trailing FY2024)

≈ 2.6–3.0x

Analyst (HK$0.08 / 3.10 cents); Lixinger shows 2.95x

P/B

≈ 0.65–0.67x

Equity HK$245.9m (FY2024); HK$242.3m (Jun 2025)

EV/EBITDA (FY2024)

≈ 1.4x

EV ≈ HK$159m − HK$66.6m net cash (excl. leases) ≈ HK$92m, divided by EBITDA HK$110.8m; analyst-computed

EV/Sales (FY2024)

≈ 0.17x

Analyst

Dividend yield

≈ 9.3%

HK0.75 cents / HK$0.08; Lixinger 9.26%

Peer reference

Hang Seng printing and packaging sub-industry: P/E 231.8x, P/B 1.58x, yield 1.59% (aggregate, distorted)

Lixinger

Per-Share Data and Dividends & Capital Returns

MetricFY2020FY2021FY2022FY2023FY2024

Final DPS (HK cents)

0.0750.250.2000.75

Total dividend (HKD Mn)

1.55.04.0015.0

Payout ratio (%)

913332024

Analyst Conclusions

Management guidance

  • FY2025 PBT not less than HK$38.0m (unaudited; issued before the audit issue surfaced).

  • Qualitative guidance: lower capex, RFID and Europe as growth vectors, prudent finance.

  • No FY2026 guidance.

Consensus: no sell-side coverage or consensus estimates identified.

Bull case

  1. The operating business may be intact. The board stated on 30 Jun 2026 that operations were normal in all material respects. H1 2025 still delivered HK$24.3m of net profit and a 47.1% gross margin.

  2. The payments flagged are small relative to the group. Combined ≈HK$3.3m against equity of HK$242m. If the forensic findings are contained to the Bangladesh unit and remediated, a resumption could re-rate a stock that traded near 0.65x book and about 3x earnings with a high yield.

  3. The footprint suits tariff-era sourcing. The Bangladesh, Vietnam, India and Mexico plants match brands' China+1 and tariff-avoidance moves. The group has a record of strong operating leverage when volumes return (FY2024 EBIT HK$77m on revenue +48%).

Bear case

  1. The investigation could widen. PwC was told the payments facilitated local-authority approvals. The earliest dates from FY2018, and PwC said it had received no documentation. A finding that implicates management integrity could prevent resumption (guidance item (b)) and lead to delisting after 30 Sep 2027.

  2. The pattern of auditor exits is a red flag in itself. EY resigned over the scope and fees for overseas work. PwC was removed after insisting on its own Bangladesh component team assessing the investigators. Removing an auditor that is pressing on scope historically correlates with adverse outcomes.

  3. Earnings were already falling before the issue. FY2025 PBT was guided down by up to 49%, US demand was collapsing and opex was rising. A reset FY2025 base, plus investigation and audit costs (Grant Thornton fee ≈HK$2.9m), compresses value even on a clean outcome. Minority holders also have no liquidity while suspended.

Catalysts and monitorables (next 12 months)

  1. Publication of the forensic investigation findings (PAL Advisory) and the Independent Committee's conclusions.

  2. Publication of audited FY2025 results by Grant Thornton (the original plan targeted Aug 2026), including any audit qualification, prior-period adjustments (the FY2018 PP&E entry) and the FY2025 dividend decision.

  3. 2026 interim results (Listing Rules deadline 31 Aug 2026) and quarterly resumption updates (around 30 Sep 2026, around 31 Dec 2026, and onward).

  4. Results of the independent internal-control review.

  5. Any regulatory referral in Bangladesh or Hong Kong, or any customer (brand) reaction to the compliance findings.

  6. Trading conditions: US tariffs, EU apparel imports, and the RFID share of revenue.

  7. The 30 Sep 2027 long-stop date for resumption.

Analyst verdict

Before March 2026, Cirtek looked like a classic overlooked Hong Kong small-cap. It was a niche apparel-trims maker that had spent five years and its IPO proceeds building plants in every major garment-export country. In FY2024 it began to harvest that investment: revenue rose 48%, gross margin reached 49%, ROE was 28%, it had net cash on bank debt, and it traded at about 3x earnings with a 9% yield. The industrial logic of near-shoring trims to garment hubs is sound, and the customer base is unusually diversified.

That thesis is now subordinate to a governance question that cannot yet be answered. The amounts PwC flagged are financially small. What PwC was told they were for, and how the board responded, is not small. The board replaced the auditor rather than accept its conditions on investigator vetting — a choice the company explains as a practical dispute over Bangladesh audit logistics. EY's departure five months earlier, also linked to the scope of overseas audit work, adds to the concern.

The SEHK resumption guidance makes management integrity an explicit test. The equity value therefore depends on the outcome of the investigation, not on the label cycle. Our view: a non-investable / binary situation until audited FY2025 accounts and the forensic report are published.

If clean: the evidence points to a modest operating business. FY2025 PBT of roughly HK$38m on a book of about HK$240m would justify a re-rating toward book value.

If adverse: integrity findings, a qualified audit or a wider scope would make delisting by September 2027 a realistic outcome, and minority shareholders would be left with illiquid, unlisted exposure.

Investors should weight the downside scenario heavily given (i) the controlling family's 65% stake, (ii) the absence of documentation PwC reported, and (iii) the company's poor track record on small acquisitions.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleAge (FY2024 AR)TenureBackground / educationSource

Chan Sing Ming, Barry (陳醒明)

Chairman, Executive Director; Nomination Committee chair

65

MD since Feb 1992; director since 25 Jan 2019

Higher Certificate in Fashion and Clothing Manufacture, Hong Kong Polytechnic (1984); 42+ years in apparel labels and trims; controlling shareholder

FY2024 AR

Law Miu Lan, Candy (羅妙蘭)

Chief Executive Officer, Executive Director; Remuneration Committee member

62

Assistant MD since Sep 1994; CEO and director since 17 May 2019

Same HK Polytechnic certificate (1984); 39+ years in the industry; spouse of the Chairman

FY2024 AR

Chan Tsz Fung, James (陳梓峰)

Executive Director; product development manager, Charming Printing; Nomination Committee member

35

Joined Oct 2013; director since 17 May 2019

Studied a diploma of engineering at Deakin University (2011–12); oversees product development and European sales; son of the Chairman and CEO; holds 12m shares (0.6%)

FY2024 AR

Lam Chor Ki, Dick (林楚祺)

Independent Non-executive Director; Audit and Nomination Committees

59

Since 21 Feb 2020

BBA, Hong Kong Baptist University; MA in Electronic Business, City University of Hong Kong; finance roles at AIA, Lexmark and Fellowes; VP Asian Operations at ECI (Huizhou) since 2012

FY2024 AR

Lee Tak Cheong (李德昌)

Independent Non-executive Director; Remuneration Committee chair; Audit and Nomination Committees

54

Since 21 Feb 2020

BEng, University of Hong Kong; MBA, CUHK; former GM and operational director of Charming Printing (2009–2014); director of Dreamcubics 3D Printing

FY2024 AR

Luk Mei Yan (陸美恩)

Independent Non-executive Director; Audit Committee chair; Remuneration and Nomination Committees

60

Since 25 Jun 2021

BCom (Accounting), Curtin; CPA Australia; HKICPA member; former INED of eprint Group (1884); accounting manager at Advanced Finishing Systems (HK)

FY2024 AR

Executive Leadership Team

NameRoleSinceNotes

Chew Yong Hock (周榮福), 66

Sales and marketing director, Charming Printing

Jul 2012

32+ years in the industry

Fung Hong Keung (馮康強), 62

Chief Financial Officer, Charming Printing

Feb 2021

Former ED, CFO and company secretary of eprint Group (2012–16); FCCA, HKICPA

Richard Phillip Ringeisen, 66

President, Charming US

Feb 2011

Ex-US Label, Alkahn Labels, Integra Trim

Liao Wenwei (廖文偉), 56

General manager, Charming China

Aug 2009

Former factory manager, Boluo Shiwan Chuangmei Printing Factory

Chan Wai Shing, Kevin (陳偉成), 50

Company secretary; finance and accounts manager

Feb 2016 (company secretary from May 2019)

FCCA; ICSA

Major Shareholders

HolderShares% of issuedSource

Charming International Ltd (Barry Chan 51% / Candy Law 49%)

1,308,000,00065.4

FY2024 AR

Chan Tsz Fung (James Chan)

12,000,0000.6

FY2024 AR

Treasury shares (company)

8,530,0000.4

Monthly return, 31 Mar 2026

Public float

≈ 33–34%

≥ 25% confirmed Aug 2025

Interim Results, 28 Aug 2025

Institutional holders (top 10)

Not publicly disclosed; no other holder above 5% was identified in the sources reviewed

——

Competitive Landscape

Key Competitors

CompetitorType / ownershipOverlap with CirtekScale indicatorSource

Avery Dennison (Solutions Group; formerly RBIS / Paxar)

NYSE: AVY

Global leader in apparel labels, tags and RFID

FY2025 group net sales ≈ US$8.9bn; Solutions Group US$2,762m; "Apparel and other" US$1,812m

Avery Dennison FY2025 release / 10-K

CCL Industries (Checkpoint / apparel labels)

TSX: CCL.B

Apparel labelling and RFID / EAS

——

Nilörngruppen (Nilörn)

Nasdaq Stockholm: NIL.B

Labels, packaging and accessories for fashion brands; plants in Bangladesh, India, Turkey, China and Pakistan

FY2025 net sales SEK 945m (flat), operating profit SEK 73.4m

Nilörn Q4 2025 report

SML Group

Private, Hong Kong

Labels, tags and RFID retail solutions

——

Trimco Group

Private

Labels and trims for brands

——

ITL Group

Private

Apparel labels and packaging

——

Finotex

Private

Woven and printed labels; Americas focus

——

Bally Labels AG

Owned by Nilörn

European labels

—

roic.ai summary of Nilörn

Local converters in China, Bangladesh, India and Vietnam

Private SMEs

Price competition on commodity labels

——

eprint Group (HKEX: 1884)

Listed (HK)

Overlap with Print100 in HK quick-print

——

“—” = not publicly disclosed.

Peer Comparison FY2025

MetricCirtek (FY2024)Avery Dennison (FY2025)Nilörn (FY2025)

Revenue (local currency)

HK$551.0m

US$8.9bn group / US$2.76bn Solutions

SEK 945m

Revenue (≈USD Mn, analyst conversion)

≈ 70.6 at HK$7.8/US$

≈ 8,900

≈ 90–95 (indicative)

Revenue growth (%)

48.010

Gross margin (%)

49.1—

≈ 46.7

Operating margin (%)

≈ 14.0 (analyst EBIT)

—

≈ 7.8

Recent Developments

--

Company Snapshot

$70.6M

Revenue

1,424

Employees

2019

Founded

Kowloon, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Margin quality. FY2024 gross margin of 49.1% and H1 2025 of 47.1%, against about 46.7% at listed peer Nilörn (FY2024 Results; Interim 2025; Nilörn FY2025).
  • Customer diversification. Top five customers were 8.7% of FY2024 sales and the largest 4.1% (FY2024 AR).
  • Footprint in garment-export hubs. Plants in China, Bangladesh, Vietnam, India and Turkey, plus Mexico and Guatemala; sales in more than 40 markets (FY2024 AR).
  • Balance sheet. Bank debt of HK$4.0m against cash of HK$76.2m and pledged deposits of HK$4.4m at 30 Jun 2025; HK$116.7m of undrawn facilities (Interim 2025).
  • Proven operating leverage. EBIT rose from −HK$16.0m (FY2023) to HK$77.0m (FY2024) on +48% revenue.
  • Owned Bangladesh capacity. Operational since Feb 2024; Bangladesh revenue +95% in FY2024 (FY2024 Results).

Weaknesses

  • Control environment. Unsupported cash payments in Bangladesh: ≈HK$2.5m (BDT 40.9m) recorded under PP&E in FY2018 and ≈HK$0.82m (BDT 12.7m) recorded as expenses in FY2025 (PwC letter, 29 May 2026).
  • The HK$/BDT conversion for the 2018 figure appears internally inconsistent with 2018 exchange rates. It is reported here as stated by PwC.
  • Auditor churn. EY resigned (Oct 2025) and PwC was removed (May 2026) within eight months (EGM circular).
  • Concentrated family control. 65.4% held by the Chairman and CEO (spouses); their son is the third executive director (FY2024 AR).
  • M&A record. TrueCount, Print100 and Primway were all impaired within one to two years (FY2022–23 notes).
  • Cost structure. Admin expense was 24.6–32.5% of revenue over FY2020–24 (§6.2).
  • Earnings volatility. Net margin ranged from −6.9% to 11.2% over FY2020–24 (§6.2).

Opportunities

  • RFID cross-sell to the existing base; the RFID share of revenue rose "significantly" in FY2024 (FY2024 MD&A).
  • Europe via Primway. Primway introduced French customers and orders in 2024–25 (H1 2025 MD&A).
  • Tariff-driven sourcing shifts to Bangladesh, Vietnam, India and Mexico, where Cirtek already produces (H1 2025 MD&A).
  • Eco-materials demand from major brands (H1 2025 MD&A).
  • Capex taper. Management said peak investment had passed, implying stronger free cash flow (FY2024 Chairman's Statement).
  • Valuation re-rating if the investigation clears management. The pre-suspension P/E was about 3x and P/B about 0.67x (Lixinger).

Threats

  • Delisting. Trading must resume by 30 Sep 2027 (Resumption Guidance, 26 Jun 2026).
  • Regulatory and legal exposure. PwC was told the Bangladesh payments were used to facilitate local-authority approvals (PwC letter). This could raise anti-bribery questions and customer-compliance consequences if substantiated.
  • US tariffs. US customer revenue fell 44% in H1 2025 (Interim 2025).
  • Bangladesh political risk. Unrest in Aug 2024 delayed financial confirmations (TipRanks summary).
  • Competition from scaled RFID players. Avery Dennison's Solutions Group had sales of US$2.76bn in FY2025 (Avery 10-K).
  • Demand slowdown. FY2025 PBT guided down to at least HK$38.0m (Profit Warning, 20 Mar 2026).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
14 Mar 2025Positive profit alert: FY2024 PBT expected ≥ HK$65.0m vs FY2023 loss of ≈HK$19.7m Announcement 14 Mar 2025Turnaround confirmed
28 → 31 Mar 2025FY2024 results board meeting postponed by three days to finalise the audit TipRanksEarly sign of audit-timeline strain
31 Mar 2025FY2024 results: revenue HK$551.0m (+48%), net profit HK$61.9m, final dividend HK0.75 cents FY2024 Results AnnouncementRecord year
25 Apr 2025FY2024 Annual Report; AGM notice proposing re-appointment of EY—
20 Jun 2025AGM (dividend; re-election of Barry Chan and Luk Mei Yan) AGM notice; Interim 2025Dividend payable of HK$15.0m recognised at 30 Jun 2025
H1 2025Buyback of 50,000 shares (HK$2,000) Interim 2025Immaterial
18 Jul 2025Scheduled payment of the FY2024 final dividend FY2024 ResultsCash return of HK$15.0m
28 Aug 2025H1 2025 interim results: revenue −2.4%, net profit −22%; no interim dividend Interim ResultsDeceleration; US −44%
14 Sep 2025Expiry of the 2,000,000 share options granted in 2020 Interim 2025—
26 Sep 20252025 Interim Report published HKEXnews—
15 Oct 2025EY resigns over an FY2025 audit-fee disagreement tied to expanded overseas audit work; PwC appointed TipRanks summary; EGM circularFirst auditor change; overseas audit scope flagged
17 Mar 2026Board meeting date notice for FY2025 results and final dividend ETNet announcement list—
20 Mar 2026Profit warning: FY2025 PBT ≥ HK$38.0m vs HK$74.7m Profit WarningEarnings down up to ~49%
30 Mar 2026PwC letter to the Audit Committee; inside-information announcement of the results delay and payment concerns Announcement 30 Mar 2026Trigger event
31 Mar 2026Trading suspended Announcement 31 Mar 2026Liquidity frozen for minority holders
17 & 28 Apr 2026PwC meets the Audit Committee; the company proposes local Bangladesh investigators and raises communication concerns about PwC's component team PwC letter (EGM circular)Dispute crystallises
8 May 2026PwC follow-up letter on investigator appointment and scope EGM circularPwC asks to assess investigator competence and independence
Early to 11 May 2026Audit Committee seeks quotes from and meets several audit firms EGM circularAuditor shopping begins
22 May 2026Audit Committee recommends replacing PwC; board approves; PwC's letter to the company EGM circular—
29 May 2026PwC removed (effective date); announcement of the proposed change to Grant Thornton (致同) EGM circular; ETNetSecond auditor change in eight months
1 Jun 2026Circular and EGM notice; PwC's statement of circumstances reproduced in full EGM circularKey governance document
18 Jun 2026EGM postponed because of a black rainstorm warning ETNetProcedural
23 Jun 2026Independent Committee (3 INEDs) formed; PAL Advisory Limited (上邦永晉諮詢有限公司) appointed forensic investigator Quarterly Update 30 Jun 2026Responds to the expected guidance
24 Jun 2026EGM held; poll results published (auditor resolutions). SEHK resumption-guidance letter dated the same day. ETNet; Lixinger; Announcement 26 Jun 2026Grant Thornton in office
26 Jun 2026Resumption guidance announced; delisting long-stop date 30 Sep 2027 Resumption Guidance AnnouncementDefines the path to relisting
30 Jun 2026First quarterly resumption update; business operations described as normal in all material respects Quarterly Update—
3 Jul 2026—
Aug 2026 (planned)Grant Thornton's planned timetable targeted FY2025 results and annual report in Aug 2026. EGM circularKey catalyst
31 Aug 2026Listing Rules deadline for 2026 interim results.Probable further non-compliance if the FY2025 audit was outstanding
By 30 Sep 2026Second quarterly resumption update due. Resumption guidance—

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

9 charts
Income Statement: Revenue & Gross Profit (FY2020–FY2024): Revenue rose from HKD 259.3 Mn in FY2020 to HKD 551 Mn in FY2024.
Cirtek Holdings Limited — Income Statement: Revenue & Gross Profit (FY2020–FY2024)
Series (HKD Mn)FY2020FY2021FY2022FY2023FY2024
Revenue259.3362.5408.6372.3551
Cost of sales129.1204.5235.1209.8280.4
Gross profit130.2158173.5162.6270.6
Revenue per employee262345351305387

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Cirtek Holdings — Final Results FY2024 (31 Mar 2025) (www1.hkexnews.hk)
  2. Cirtek Holdings — 2024 Annual Report (25 Apr 2025) (hkexnews.hk)
  3. Cirtek Holdings — Final Results FY2023 (27 Mar 2024) (www1.hkexnews.hk)
  4. Cirtek Holdings — Final Results FY2021 (30 Mar 2022) (www1.hkexnews.hk)
  5. Cirtek Holdings — Final Results FY2019 (30 Mar 2020) (www1.hkexnews.hk)
  6. Cirtek Holdings — Interim Results H1 2025 (28 Aug 2025) (www1.hkexnews.hk)
  7. Cirtek Holdings — Interim Results H1 2024 (Chinese, 28 Aug 2024) (hkexnews.hk)
  8. Cirtek Holdings — Profit Warning (20 Mar 2026) (www1.hkexnews.hk)
  9. Cirtek Holdings — Positive profit alert (Chinese, 14 Mar 2025) (hkexnews.hk)
  10. Cirtek Holdings — Inside Information / delay of 2025 results (30 Mar 2026) (www1.hkexnews.hk)
  11. Cirtek Holdings — Suspension of Trading (31 Mar 2026) (www1.hkexnews.hk)
  12. Cirtek Holdings — Circular on proposed change of auditor and EGM notice, incl. PwC letter (Chinese, 1 Jun 2026) (pdf.dfcfw.com)
  13. Cirtek Holdings — EGM notice (English, 1 Jun 2026) (www1.hkexnews.hk)
  14. Cirtek Holdings — EGM poll results (Chinese, 24 Jun 2026) (pdf.dfcfw.com)
  15. Cirtek Holdings — Resumption Guidance (26 Jun 2026) (www1.hkexnews.hk)
  16. Cirtek Holdings — Quarterly Update on Resumption (30 Jun 2026): and: www1.hkexnews.hk · static.cninfo.com.cn
  17. Cirtek Holdings — Bangladesh construction agreement extension (1 Apr 2022) (www1.hkexnews.hk)
  18. Cirtek Holdings — Change of Cayman registrar (10 Jan 2025) (www1.hkexnews.hk)
  19. TipRanks (Hebrew) — Cirtek change of auditor to PwC (15 Oct 2025) (il.tipranks.com)
  20. TipRanks — Cirtek delay amid Bangladesh unrest (tipranks.com)
  21. TipRanks — FY2024 board meeting postponement (tipranks.com)
  22. ETNet — 1433 announcements list (etnet.com.hk)
  23. ETNet — 1433 company profile (content.etnet.com.hk)
  24. Lixinger — 01433 announcements and valuation snapshot (lixinger.com)
  25. iTiger — March 2026 monthly share return summary (itiger.com)
  26. Minichart — FY2025 profit warning summary (minichart.com.sg)
  27. Avery Dennison — Q4 and FY2025 results (4 Feb 2026) (businesswire.com)
  28. Avery Dennison — FY2025 Form 10-K (sec.gov)
  29. Nilörn — Interim Report Q4 2025 (inderes.se)
  30. Stockanalysis — Nilörn income statement (stockanalysis.com)
  31. Context.ph — Cirtek Holdings Philippines (disambiguation) (context.ph)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.